| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.037 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.04 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |